10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 328 filers reported holding 10X GENOMICS INC in Q3 2021. The put-call ratio across all filers is 2.03 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $726,309 | -25.0% | 17,608 | +1.5% | 0.00% | -33.3% |
| Q2 2023 | $968,910 | +101462.9% | 17,351 | +1.2% | 0.00% | 0.0% |
| Q1 2023 | $954 | +43.2% | 17,139 | -6.2% | 0.00% | +50.0% |
| Q4 2022 | $666 | -99.8% | 18,264 | +28.2% | 0.00% | 0.0% |
| Q3 2022 | $406,000 | -31.1% | 14,245 | +9.5% | 0.00% | 0.0% |
| Q2 2022 | $589,000 | -66.4% | 13,006 | +10.6% | 0.00% | -71.4% |
| Q4 2021 | $1,751,000 | -15.5% | 11,758 | -17.4% | 0.01% | -36.4% |
| Q3 2021 | $2,073,000 | -30.2% | 14,243 | -6.1% | 0.01% | -38.9% |
| Q2 2021 | $2,970,000 | – | 15,167 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 8,185,565 | $952,538,000 | 99.56% |
| Foresite Capital Management I, LLC | 2,750,000 | $342,870,000 | 96.54% |
| Foresite Capital Management II, LLC | 3,503,528 | $436,820,000 | 95.05% |
| 12 West Capital Management LP | 1,922,000 | $239,635,000 | 11.66% |
| FINANCIAL CONSULATE, INC | 163,366 | $20,368,000 | 9.67% |
| JS Capital Management LLC | 606,400 | $75,606,000 | 3.91% |
| Asymmetry Capital Management, L.P. | 43,512 | $5,425,000 | 3.49% |
| Pinz Capital Management, LP | 55,400 | $6,907,000 | 2.52% |
| HAMILTON LANE ADVISORS LLC | 37,087 | $4,624,000 | 2.24% |
| RTW INVESTMENTS, LP | 660,933 | $82,405,000 | 1.98% |